Procurement Opportunity: InjAcetylcysteine 200mg,InjAdenosine 6mg or 1ml,InjAdrenaline 1ml IV,Inj Amiodarone 50mgormlor 3ml,

To participate in the tender process, the eligibility requirements necessitate that the bidder be a registered entity capable of supplying injectable medications. This includes manufacturers, suppliers, or authorized dealers in pharmaceuticals. Bidders seeking exemptions regarding experience or turnover will need to upload supporting documentation for evaluation.

Bid submissions must include several required certificates, including compliance with BoQ specifications and any other documents that testify to the qualifications of the supplier. Any exemptions claimed must be supported with appropriate documents.

The registration process entails applying through the official government electronic marketplace (GeM) portal, subsequently presenting necessary documents, certifications, and the EMD as specified in the tender.

Accepted document formats generally include PDF and other standard formats that can be easily verified by the issuing authority. Bidders must ensure that all files are legible and clearly presented.

Yes, bidders must comply with the technical specifications for each injectable product as outlined in the BoQ. It is essential that all items meet these requirements to ensure quality and safety standards.

Bidder products must meet national and international quality standards related to pharmaceuticals. This includes adherence to Good Manufacturing Practices (GMP) and obtaining relevant certification for each product supplied.

Bidders must demonstrate compliance requirements by submitting appropriate certifications that reflect their capability to deliver the specified products meeting established standards.

The testing criteria involve evaluating the characteristics of the products stipulated in the BoQ. Products must be tested for safety, potency, and efficacy to meet health regulations.

The EMD amount for this tender is ₹23,000, which must accompany the bid submission to ensure commitment to the bidding process and compliance with tender rules.

After the award of the tender, a performance security will be required, specifics of which will be outlined in the agreement to ensure the successful supply of products as per the contract.

Payment terms will be specified post-evaluation and upon award notification, typically requiring adherence to agreed milestones aligned with product delivery schedules.

The price evaluation considerations will be item-wise, ensuring that not just cost but also quality and compliance with technical specifications are duly considered for awarding the contract.

While the overall process will entail multiple stages, bidders should be aware that specific timelines and deadlines for submission, evaluation, and award notifications will be set by the issuing authority.

MSEs may benefit from several provisions in the tender, including exemptions from experience and turnover requirements, encouraging their participation in the supply of critical health commodities.

Yes, the tender has special provisions for startups, designed to enhance their inclusion and participation, providing similar exemptions as offered to MSEs.

This tender promotes local sourcing and production of pharmaceuticals by adhering to 'Make in India' policies, which encourages domestic manufacturers and enhances local capabilities in healthcare supply chains.

Indeed, local content and procurement rules are integral to this tender, favoring suppliers who can demonstrate substantial local manufacturing within the supply chain to promote national economic interests.